topotecan has been researched along with Ependymoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Finlay, JL; Gardner, S; Liebes, LF; Tran, HC; Weiner, HL | 1 |
| Allen, JC; Belasco, JB; Fisher, PG; Janss, AJ; Minturn, JE; Patti, R; Phillips, PC | 1 |
1 trial(s) available for topotecan and Ependymoma
| Article | Year |
|---|---|
A phase II study of metronomic oral topotecan for recurrent childhood brain tumors.
Topics: Brain Neoplasms; Brain Stem Neoplasms; Child; Disease-Free Survival; Ependymoma; Female; Glioma; Humans; Male; Neuroectodermal Tumors, Primitive; Topoisomerase I Inhibitors; Topotecan; Treatment Outcome | 2011 |
1 other study(ies) available for topotecan and Ependymoma
| Article | Year |
|---|---|
Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer.
Topics: Adult; Antineoplastic Agents; Brain Neoplasms; Cerebellar Neoplasms; Ependymoma; Humans; Injections, Spinal; Male; Medulloblastoma; Meningeal Neoplasms; Neoplasm Recurrence, Local; Pilot Projects; Topotecan; Treatment Outcome; Young Adult | 2014 |